RETATRUTIDE 20mg/50mg

Peptide: Retatrutide 20mg/50mg
Retatrutide is a synthetic peptide that acts as a triple agonist targeting glucagon, GIP, and GLP-1 receptors. It is studied for integrated metabolic signaling, glucose regulation, appetite pathways, energy expenditure, and body-weight regulation. It is intended strictly for research purposes and is not approved for human or veterinary use outside regulated clinical trials.

Research Applications
Triple-Receptor Metabolic Signaling
Used to study combined activation of GCGR, GIP, and GLP-1 pathways.
Sources: https://pubmed.ncbi.nlm.nih.gov/37366315/

Glucose Regulation & Insulin Dynamics
Applied in research on glycemic control, insulin signaling, and incretin biology.
Sources: https://pubmed.ncbi.nlm.nih.gov/37366315/

Energy Balance Research
Used to investigate appetite, body-weight regulation, and metabolic pathway integration.
Sources: https://pubmed.ncbi.nlm.nih.gov/36882274/